<DOC>
	<DOCNO>NCT03010475</DOCNO>
	<brief_summary>This trial conduct Europe . Tha aim trial investigate effect oral semaglutide pharmacokinetics furosemide rosuvastatin healthy subject .</brief_summary>
	<brief_title>A Trial Investigating Effect Oral Semaglutide Pharmacokinetics Furosemide Rosuvastatin Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Informed consent obtain trialrelated activity . Trialrelated activity procedure carry part trial , include activity determine suitability trial Male female , age 1865 year ( inclusive ) time sign informed consent Body mass index ( BMI ) 20.029.9 kg/m^2 ( inclusive ) Considered generally healthy base medical history , physical examination , result vital sign , electrocardiography clinical laboratory test perform screen visit , judge investigator Smoker ( define subject smoking least one cigarette equivalent per day ) Any blood draw excess 25 mL past month , donation blood plasma excess 400 mL within 3 month precede screen History major surgical procedure involve stomach potentially affect absorption trial product ( e.g . subtotal total gastrectomy , sleeve gastrectomy , gastric bypass surgery ) Have personal family history myopathy Previous history muscular toxicity another HMGCoA reductase inhibitor fibrate ThyroidStimulating Hormone outside low limit normal minus 10 percent upper limit normal plus 10 percent Creatine kinase 5 x upper limit normal Asian subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>